Skip to main content

Table 1 Characteristics of the study population

From: Oral health of children and adolescents with or without attention deficit hyperactivity disorder (ADHD) living in residential care in rural Rhineland-Palatinate, Germany

 Children and adolescents with ADHD (study group)
(n = 34)
Children and adolescents without ADHD (control group)
(n = 45)
Gender:
 male27 (79.4%)31 (68.9%)
 female7 (20.6%)14 (31.1%)
Age (years):
 mean ± SD12.38 ± 1.8912.76 ± 1.91
 median/minimum/maximum12/9/1513/9/15
Medication for ADHD:
 • methylphenidate14 (41.2%)0
 • methylphenidate and risperidone8 (23.5%)0
 • amphetamine and risperidone2 (5.9%)0
 • atomoxetine and risperidone2 (5.9%)0
 • no medication8 (23.5%)45 (100%)
Months in residential care:
 mean ± SD21.29 ± 15.7425.24 ± 30.27
 median/minimum/maximum19/0.7/6217/1/149
ADHD classification (ICD-10):
 F 90.013 (38.2%)N/A
 F 90.120 (58.8%)N/A
 F 90.81 (2.9%)N/A